Association of white blood cell count with systolic blood pressure within the normotensive range

Journal of Human Hypertension

Volumn 20, Issue 5, 2006, Pages 341-347

  Orakzai, R H ^a   Orakzai, S H ^a   Nasir, K ^a,b   Santos, R D ^c,d   Rana, J S ^a   Pimentel, I ^c   Carvalho, J A M ^c   Meneghello, R ^c   Blumenthal, R S ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Blood pressure; Cardiovascular disease; Inflammation; White blood cell

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEALTH SURVEY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LEUKOCYTE COUNT; LINEAR REGRESSION ANALYSIS; MALE; PHYSICAL ACTIVITY; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ADULT; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; LEUKOCYTE COUNT; LINEAR MODELS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 33646056711     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001992     Document Type: Article

References (50)

1. Chobanian A, Bakris G, Black H, Cushman WC, Green LA, Izzo JL et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. JAMA 2003; 289: 2560-2572.
2. Chon H, Gaillard C, van der Meijden BB, Digstelbloem HM, Kraaijenhagen RJ, van Leenen D et al. Broadly altered gene expression in blood leukocytes in essential hypertension is absent during treatment. Hypertension 2004; 43: 947-951.
3. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age-specific relevance of casual blood pressure to vascular mortality. Lancet 2002; 360: 1903-1913.
4. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345(18): 1291-1297.
5. Kannel WB, Anderson K, Wilson PW. White blood cell count and cardiovascular disease. Insights from the Framingham Study. JAMA 1992; 267: 1253-1256.
6. Zalokar JB, Richard JL, Claude JR. Leukocyte count, smoking and myocardial infarction. N Engl J Med 1981; 304: 465-468.
7. Friedman GD, Klatsky AL, Siegelaub AB. The leukocyte count as a predictor of myocardial infarction. N Engl J Med 1974; 290: 1275-1278.
8. Lee CD, Folsom AR, Nieto FJ, Chambless LE, Shahar E, Wolfe DA. White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: Atherosclerosis risk in communities study. Am J Epidemiol 2001; 154: 758-764.
9. Mehta JL, Nichols WW, Mehta P. Neutrophils as potential participants in acute myocardial ischemia: Relevance to reperfusion. J Am Coll Cardiol 1988; 11: 1309-1316.
10. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340: 115-126.
11. Alexander RW. Inflammation and coronary artery disease. N Engl J Med 1994; 331: 468-469.
12. Mugge A, Lopez JA. Do leukocytes have a role in hypertension? Hypertension 1991; 17: 331-333.
13. Sinisalo J, Paronen J, Mattila KJ, Syrjala M, Alfthan G, Palosuo T et al. Relation of inflammation to vascular function in patients with coronary heart disease. Atherosclerosis 2000; 149: 403-411.
14. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993; 362: 801-809.
15. Boyle JJ. Association of coronary plaque rupture and atherosclerotic inflammation. J Pathol 1997; 181: 93-99.
16. Friedman GD, Selby JV, Quesenberry Jr CP. The leukocyte count: A predictor of hypertension. J Clin Epidemiol 1990; 43: 907-911.
17. Panza JA, Quyyumi AA, Brush Jr JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-27.
18. Bautista LE, Lopez-Jaramillo P, Vera LM, Casas JP, Otero AP, Guaracao AI. Is C-reactive protein an independent risk factor for essential hypertension. J Hypertens 2001; 19: 857-861.
19. Gillum RF, Mussolino ME. White blood cell count and hypertension incidence. The NHANES 1 Epidemiological Follow-up Study. J Clin Epidemiol 1994; 47: 911-919.
20. Sesso H, Buring J, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and the risk of developing hypertension. JAMA 2003; 290: 2945-2951.
21. Bautista LE, Vera LM, Arenas IA, Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin-6 and TNF-α) and essential hypertension. J Hum Hypertens 2005; 19(2): 149-154.
22. Schillaci G, Pirro M, Gemelli F, Pasqualini L, Vaudo G, Marchesi S et al. Increased C-reactive protein concentrations in never-treated hypertension: The role of systolic and pulse pressures. J Hypertens 2003; 21(10): 1841-1846.
23. Abramson J, Weintraub W, Vaccarino V. Association between pulse pressure and C-reactive protein among apparently healthy US adults. Hypertension 2002; 39: 197-202.
24. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN et al. Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: Blood pressure measurement in humans: A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005; 45: 142-161.
25. Bautista LE, Atwood JE, O'Malley PG, Taylor AJ. Association between C-reactive protein and hypertension in healthy middle-aged men and women. Coron Artery Dis 2004; 15(6): 331-336.
26. Corre F, Lellouch J, Schwartz D. Smoking and leukocyte counts. Results of an epidemiological survey. Lancet 1971; 2: 632-634.
27. Petitti DB, Kipp H. The leukocyte count: Associations with intensity of smoking and persistence of effect after quitting. Am J Epidemiol 1986; 123: 89-95.
28. Shankar A, Kelin B, Klein R. Relationship between white blood cell count and incident hypertension. Am J Hypertens 2004; 17: 233-239.
29. Nakanishi N, Sato M, Shirai K, Suzuki K, Tatara K. White blood cell count as a risk factor for hypertension; a study of Japanese male office workers. J Hypertens 2002; 20: 851-857.
30. Ernst E, Hammerschmidt DE, Bagge U, Matrai A, Dormandy JA. Leukocytes and the risk of ischemic diseases. JAMA 1987; 257: 2318-2324.
31. Dinerman JL, Mehta JL, Saldeen TG, Emerson S, Wallin R, Davda R et al. Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction. J Am Coll Cardiol 1990; 15: 1559-1563.
32. Ross R. The pathogenesis of atherosclerosis - An update. N Engl J Med 1986; 314: 488-500.
33. Pontremoli S, Salamino F, Sparatore B, De Tullio R, Patrone M, Tizianello A et al. Enhanced activation of the respiratory burst oxidase in neutrophils from hypertensive patients. Biochem Biophys Res Commun 1989; 158: 966-972.
34. Bautista LE. Inflammation, endotheliail dysfunction, and the risk of high blood pressure: Epidemiologic and biological evidence. J Hum Hypertens 2003; 17: 223-230.
35. Weiss SJ, LoBuglio AF. Biology of disease: Phagocyte generated oxygen metabolites and cellular injury. Lab Invest 1982; 47: 5-18.
36. Ohlstein EH, Nichols AJ. Rabbit polymorphonuclear neutrophills elicit endothelium-dependent contraction in vascular smooth muscle. Circ Res 1989; 65: 917-924.
37. Whorton AR, Montgomery ME, Kent RS. Effect of hydrogen peroxide on prostaglandin production and cellular integrity in culture porcine aortic endothelial cells. J Clin Invest 1985; 76: 295-302.
38. Katusic ZS, Vanhoutte PM. Superoxide anion is an endothelium-derived contracting factor. Am J Physiol 1989; 257: H33-H37.
39. Hingorani AD, Cross J, Kharbanda RK, Mullen MJ, Bhagat K, Taylor M et al. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation 2000; 102: 994-999.
40. Dzau VJ, Gonzalez D, Kaempfer C, Dubin D, Wintroub BU. Human neutrophils release serine proteases capable of activating prorenin. Circ Res 1987; 60: 595-601.
41. Wintroub BU, Klickstein LB, Dzau VJ, Watt KW. Granulocyte-angiotensin system: Identification of angiotensinogen as the plasma protein substrate of leukocyte cathepsin G. Biochemistry 1984; 23: 227-232.
42. Harlan JM. Lekocyte-endothelial interactions. Blood 1985; 65: 513-525.
43. Ito BR, Schmid-Schönbein G, Engler RL. Effect of leukocyte activation on myocardial vascular resistance. Blood Vessels 1990; 16: 145-166.
44. Dinerman JL, Mehta JL. Endothelial, platelet and leukocyte interaction in ischemic heart disease: Insights into potential mechanisms and their clinical relevance. J Am Coll Cardiol 1990; 16: 207-222.
45. Zucker MB, Nachmias VT. Platelet activation. Arteriosclerosis 1985; 5: 2-18.
46. Kuchel O. The autonomic nervous system and blood pressure regulation in human hypertension. In: Genest J, Kuchal O, Hamet P, Cantin M (eds). Hypertension: Physiopathology and Treatment, 2nd edn. McGraw-Hill: New York, 1983 pp 140-160.
47. Ryan SM, Waack BJ, Weno BL, Heistad DD. Increases in pulse pressure impair acetylcholine-induced vascular relaxation. Am J Physiol 1995; 268: H359-H363.
48. Hensley K, Robinson KA, Gabbita SP, Salsman S, Floyd RA. Reactive oxygen species, cell signaling, and cell injury. Free Radic Biol Med 2000; 28: 1456-1462.
49. Nakanishi N, Yoshida H, Okamoto M, Matsuo Y, Suzuki K, Tatara K. Association of alcohol consumption with white blood cell count: A study of Japanese male office workers. J Intern Med 2003; 253(3): 367-374.
50. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17: 151-183.